Physician

Tyler B. Vines, MD

According to 2025 Medicare claims, Tyler Vines, MD (NPI: 1730618729) practices neurology in the Augusta-Richmond County, GA-SC market, with the plurality of this provider's patient population coming from Aiken, SC. This provider's primary affiliated billing organization is WELLSTAR MEDICAL GROUP, LLC (NPI: 1275992240; TIN: 273818647) and primary practice location at 29803-1731. Vines is affiliated with the WellStar Clinical Partners Medicare ACO, LLC (ACO ID: A4803), participating under the MSSP model.

Vines' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 340 traditional Medicare patients, billed 92,596 HCPCS/CPT codes, and received $1,683,374 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 2,086 prescription claims across 296 beneficiaries totaling $645,007 in drug costs, led by Kesimpta Pen (Ofatumumab). Open Payments data shows 4 records totaling $80. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $7,212 to $645,007. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$842K$1.7M2021 Medicare payment: $26,986 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $674,635 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,329,049 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,683,374 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
202154608$26,986
202223132,613$674,635
202331669,473$1,329,049
202434092,596$1,683,374

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$323K$645K2017 Drug cost: $7,212 (USD; Tot_Drug_Cst)2018 Drug cost: $8,575 (USD; Tot_Drug_Cst)2019 Drug cost: $17,653 (USD; Tot_Drug_Cst)2020 Drug cost: $31,985 (USD; Tot_Drug_Cst)2021 Drug cost: $29,804 (USD; Tot_Drug_Cst)2022 Drug cost: $118,163 (USD; Tot_Drug_Cst)2023 Drug cost: $303,645 (USD; Tot_Drug_Cst)2024 Drug cost: $645,007 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
20171855$7,212
201842169$8,575
201944188$17,653
202068222$31,985
202179237$29,804
2022147569$118,163
20232301,371$303,645
20242962,086$645,007

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more7373$111
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more2528$89
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more152269$63
96365Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less92341$44
96372Injection of drug or substance under skin or into muscle56215$10

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Kesimpta PenOfatumumab15448$148,684
Rebif RebidoseInterferon Beta-1a/Albumin11364$134,519
Aimovig AutoinjectorErenumab-Aooe672,294$58,044
Nurtec OdtRimegepant Sulfate30728$34,985
Emgality PenGalcanezumab-Gnlm281,038$26,547

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.4$80ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Tyler B. Vines, MD?

Tedicare shows public-source Medicare data for Tyler B. Vines, MD (NPI 1730618729), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Tyler B. Vines, MD have ACO affiliation data?

Tyler B. Vines, MD is shown with ACO affiliation data for WellStar Clinical Partners Medicare ACO, LLC (MSSP, ACO ID A4803).

What billing organization is linked to Tyler B. Vines, MD?

Tyler B. Vines, MD is linked to WELLSTAR MEDICAL GROUP, LLC (billing NPI 1275992240) in the available physician profile data.

Does Tyler B. Vines, MD have Open Payments data?

Tyler B. Vines, MD has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.